To determine the impact of PFD on human NSCLC tissues, E-cadherin, α-SMA, and Ki67 were evaluated in tumor specimens from NSCLC patients who were treated with PFD for their IPF. This evidence concerns the gene MKI67 and non-small cell lung carcinoma.